Gigaxonin
| Gigaxonin | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PDB rendering based on 2ppi. | |||||||||||||
| |||||||||||||
| Identifiers | |||||||||||||
| Symbols | GAN ; GAN1; KLHL16 | ||||||||||||
| External IDs | OMIM: 605379 MGI: 1890619 HomoloGene: 32523 GeneCards: GAN Gene | ||||||||||||
| |||||||||||||
| RNA expression pattern | |||||||||||||
 | |||||||||||||
| More reference expression data | |||||||||||||
| Orthologs | |||||||||||||
| Species | Human | Mouse | |||||||||||
| Entrez | 8139 | 209239 | |||||||||||
| Ensembl | ENSG00000261609 | ENSMUSG00000052557 | |||||||||||
| UniProt | Q9H2C0 | Q8CA72 | |||||||||||
| RefSeq (mRNA) | NM_022041 | NM_001081151 | |||||||||||
| RefSeq (protein) | NP_071324 | NP_001074620 | |||||||||||
| Location (UCSC) |
Chr 16: 81.31 – 81.39 Mb |
Chr 8: 117.16 – 117.22 Mb | |||||||||||
| PubMed search | |||||||||||||
Gigaxonin also known as kelch-like protein 16 is a protein that in humans is encoded by the GAN gene.[1][2][3]
Function
Gigaxonin is a member of the cytoskeletal BTB / kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. (Kelch repeats are predicted to form a beta-propeller shape.) Gigaxonin plays a role in neurofilament architecture and is mutated in giant axonal neuropathy.[3]
See also
References
- ↑ Flanigan KM, Crawford TO, Griffin JW, Goebel HH, Kohlschutter A, Ranells J, Camfield PR, Ptacek LJ (Feb 1998). "Localization of the giant axonal neuropathy gene to chromosome 16q24". Ann Neurol 43 (1): 143–8. doi:10.1002/ana.410430126. PMID 9450783.
- ↑ Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, Demir E, Topaloglu H, Korinthenberg R, Tuysuz B, Landrieu P, Hentati F, Koenig M (Dec 2000). "The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy". Nat Genet 26 (3): 370–4. doi:10.1038/81701. PMID 11062483.
- 1 2 "Entrez Gene: GAN giant axonal neuropathy (gigaxonin)".
Further reading
- Yang Y, Allen E, Ding J, Wang W (2007). "Giant axonal neuropathy.". Cell. Mol. Life Sci. 64 (5): 601–9. doi:10.1007/s00018-007-6396-4. PMID 17256086.
- Kuhlenbäumer G, Young P, Oberwittler C, et al. (2002). "Giant axonal neuropathy (GAN): case report and two novel mutations in the gigaxonin gene.". Neurology 58 (8): 1273–6. doi:10.1212/wnl.58.8.1273. PMID 11971098.
- Ding J, Liu JJ, Kowal AS, et al. (2002). "Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin.". J. Cell Biol. 158 (3): 427–33. doi:10.1083/jcb.200202055. PMC 2173828. PMID 12147674.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Bomont P, Ioos C, Yalcinkaya C, et al. (2003). "Identification of seven novel mutations in the GAN gene.". Hum. Mutat. 21 (4): 446. doi:10.1002/humu.9122. PMID 12655563.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Benzinger A, Muster N, Koch HB, et al. (2005). "Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.". Mol. Cell Proteomics 4 (6): 785–95. doi:10.1074/mcp.M500021-MCP200. PMID 15778465.
- Allen E, Ding J, Wang W, et al. (2005). "Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival.". Nature 438 (7065): 224–8. doi:10.1038/nature04256. PMID 16227972.
- Wang W, Ding J, Allen E, et al. (2006). "Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway.". Curr. Biol. 15 (22): 2050–5. doi:10.1016/j.cub.2005.10.052. PMID 16303566.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.". Cell 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
- Leung CL, Pang Y, Shu C, et al. (2007). "Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients.". BMC Genet. 8: 6. doi:10.1186/1471-2156-8-6. PMC 1810559. PMID 17331252.
- Houlden H, Groves M, Miedzybrodzka Z, et al. (2007). "New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy.". J. Neurol. Neurosurg. Psychiatr. 78 (11): 1267–70. doi:10.1136/jnnp.2007.118968. PMC 2117591. PMID 17578852.
- Koop O, Schirmacher A, Nelis E, et al. (2007). "Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN).". Neuromuscul. Disord. 17 (8): 624–30. doi:10.1016/j.nmd.2007.03.012. PMID 17587580.
| |||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, September 01, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.